SEI INVESTMENTS CO - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$493,990
-19.2%
42,256
-7.1%
0.00%0.0%
Q2 2023$611,474
-50.9%
45,497
-39.4%
0.00%
-50.0%
Q1 2023$1,245,759
+45.6%
75,137
+63.4%
0.00%0.0%
Q4 2022$855,331
-69.6%
45,987
-79.0%
0.00%
-66.7%
Q3 2022$2,816,000
+15.6%
219,452
-37.1%
0.01%
+20.0%
Q2 2022$2,435,000
-0.4%
349,166
+18.1%
0.01%0.0%
Q1 2022$2,445,000
+107.7%
295,714
+70.1%
0.01%
+150.0%
Q4 2021$1,177,000
+27.8%
173,8440.0%0.00%0.0%
Q3 2021$921,000
+1361.9%
173,844
+819.6%
0.00%
Q1 2021$63,0000.0%18,9050.0%0.00%
Q4 2020$63,000
+12.5%
18,9050.0%0.00%
Q3 2020$56,000
-84.3%
18,905
-75.5%
0.00%
-100.0%
Q2 2020$356,000
+19.9%
77,0840.0%0.00%0.0%
Q1 2020$297,000
+518.8%
77,084
+503.7%
0.00%
Q4 2019$48,000
-91.6%
12,768
-88.6%
0.00%
-100.0%
Q1 2019$572,000
+18966.7%
112,169
+8873.5%
0.00%
Q1 2018$3,000
-40.0%
1,2500.0%0.00%
Q4 2017$5,0001,2500.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders